Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BOEHRINGER INGELHEIM

  • FDA Approval
  • Dec. 30, 2024, 18:52 UTC
  • 31

FDA approve OLODATEROL HYDROCHLORIDE

Comment Full text

SAREPTA THERAPS INC

  • FDA Approval
  • Dec. 30, 2024, 12:38 UTC
  • 28

FDA approve ETEPLIRSEN

Comment Full text

BRISTOL-MYERS SQUIBB

  • FDA Approval
  • Dec. 30, 2024, 12:38 UTC
  • 27

FDA approve NIVOLUMAB;HYALURONIDASE-NVHY

Comment Full text

BRISTOL-MYERS SQUIBB

  • FDA Approval
  • Dec. 30, 2024, 12:07 UTC
  • 37

FDA approve NIVOLUMAB;HYALURONIDASE-NVHY

Comment Full text

AMGEN INC

  • FDA Approval
  • Dec. 27, 2024, 17:44 UTC
  • 42

FDA approve USTEKINUMAB-AUUB

Comment Full text

AMGEN INC

  • FDA Approval
  • Dec. 27, 2024, 17:44 UTC
  • 39

FDA approve USTEKINUMAB-AUUB

Comment Full text

BEIGENE

  • FDA Approval
  • Dec. 27, 2024, 16:04 UTC
  • 42

FDA approve TISLELIZUMAB-JSGR

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Dec. 27, 2024, 09:46 UTC
  • 39

FDA approve DEUTETRABENAZINE

Comment Full text

RIDGEBACK BIOTHERAPEUTICS

  • FDA Approval
  • Dec. 27, 2024, 09:46 UTC
  • 27

FDA approve ANSUVIMAB-ZYKL

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Dec. 27, 2024, 09:46 UTC
  • 29

FDA approve LAMOTRIGINE

Comment Full text
  • Previous
  • 108
  • 109
  • 110
  • 111
  • 112
  • Next

Search

News categories

  • Technical Exchange News(9375)
  • Event(407)
  • SEC News(153223)
  • FDA Approval(8741)
  • Company Report(721)
  • Business News(104524)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin